Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
EULAR recommendations for the management of Behçet disease
2008449 citationsGülen Hatemi, Alan J. Silman et al.Annals of the Rheumatic Diseasesprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Bahram Bodaghi
Since
Specialization
Citations
This map shows the geographic impact of Bahram Bodaghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bahram Bodaghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bahram Bodaghi more than expected).
This network shows the impact of papers produced by Bahram Bodaghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bahram Bodaghi. The network helps show where Bahram Bodaghi may publish in the future.
Co-authorship network of co-authors of Bahram Bodaghi
This figure shows the co-authorship network connecting the top 25 collaborators of Bahram Bodaghi.
A scholar is included among the top collaborators of Bahram Bodaghi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Bahram Bodaghi. Bahram Bodaghi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Guindolet, Damien, P. Dureau, C. Edelson, et al.. (2014). Cataract surgery with or without primary lens implantation in children with chronic uveitis.. Investigative Ophthalmology & Visual Science. 55(13). 2508–2508.2 indexed citations
14.
Vallet, Hélène, P. Sève, Emmanuel Héron, et al.. (2014). Efficacy and safety of TNF-α inhibitors in non-infectious uveitis : a multicenter retrospective study. Investigative Ophthalmology & Visual Science. 55(13). 5303–5303.1 indexed citations
15.
Cardoso, João, et al.. (2014). Intravitreal dexamethasone implant in non-infectious uveitis : a one-year follow-up. Investigative Ophthalmology & Visual Science. 55(13). 2880–2880.2 indexed citations
16.
Touitou, Valérie, Coralie Bloch‐Queyrat, Aude Rigolet, et al.. (2012). Ophthalmological and Histological Manifestations of IgG4-Related Disease. Investigative Ophthalmology & Visual Science. 53(14). 6245–6245.1 indexed citations
Hatemi, Gülen, Alan J. Silman, Dongsik Bang, et al.. (2008). EULAR recommendations for the management of Behçet disease. Annals of the Rheumatic Diseases. 67(12). 1656–1662.449 indexed citations breakdown →
Quoc, E. Bui, Bahram Bodaghi, Nathalie Cassoux, et al.. (2003). Efficacy of Infliximab in the Treatment of Chronic Severe and Refractory Uveitis : A Review of Six Cases. Investigative Ophthalmology & Visual Science. 44(13). 2401–2401.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.